Van Snick J L, Masson P L
J Exp Med. 1976 Dec 1;144(6):1568-80. doi: 10.1084/jem.144.6.1568.
Human iron-saturated Lf (FeLf), which was labeled with 125I or 50Fe, was found to combine with the membrane of mouse peritoneal cells (MPC) which consisted of 70% macrophages. The following experimental data suggested the involvement of a specific receptor. (a) The binding of FeLf to MPC reached a saturation point. (b) The binding of radioactive FeLf was inhibited by preincubating the cells with cold FeLf but not with human Tf, human aggregated and nonaggregated IgG, or beef heart cytochrome c (c) Succinylation and carbamylation of FeLf resulted in a loss of its inhibiting activity on the binding of radioactive FeLf. Removal of neuraminic acid from FeLf increased its inhibitory activity. (d) The ability of apoLf to inhibit the binding of FeLf to MPC was significantly lower than that of FeLf. The existence of a Lf receptor capable of concentrating Lf released from neutrophils on the membrane of macrophages could explain the apparent blockade of the release of iron from the reticuloendothelial system, which accounts for the hyposideremia of inflammation. A receptor for FeLf was also found on mouse peritoneal lymphocytes. The affinity constant of FeLf for both lymphocytes and macrophages was 0.9 X 12(6) liter/mol. Howerver, macrophages bound three times more FeLf molecules (20 X 10(6)) per cell than did lymphocytes (7 X 10(6)).
用¹²⁵I或⁵⁰Fe标记的人铁饱和乳铁蛋白(FeLf)被发现可与由70%巨噬细胞组成的小鼠腹腔细胞(MPC)的细胞膜结合。以下实验数据表明存在一种特异性受体。(a)FeLf与MPC的结合达到饱和点。(b)用冷FeLf预孵育细胞可抑制放射性FeLf的结合,但用人转铁蛋白、人聚合和非聚合IgG或牛心细胞色素c则不能。(c)FeLf的琥珀酰化和氨甲酰化导致其对放射性FeLf结合的抑制活性丧失。从FeLf中去除神经氨酸可增加其抑制活性。(d)脱铁乳铁蛋白抑制FeLf与MPC结合的能力明显低于FeLf。一种能够将从中性粒细胞释放的乳铁蛋白聚集在巨噬细胞膜上的乳铁蛋白受体的存在,可以解释网状内皮系统中铁释放的明显阻断,这是炎症性低铁血症的原因。在小鼠腹腔淋巴细胞上也发现了FeLf受体。FeLf对淋巴细胞和巨噬细胞的亲和常数均为0.9×10⁶升/摩尔。然而,每个巨噬细胞结合的FeLf分子(20×10⁶)比淋巴细胞(7×10⁶)多三倍。